Maeve Waldron-Lynch
Observed names: M Waldron-Lynch, M. G. Waldron-Lynch, M. Waldron-Lynch, Maeve G. Waldron-Lynch, Waldron-Lynch, M., Waldron-Lynch, Maeve
Institution: Tango Therapeutics (United States)
Observed institutions: Novartis (Switzerland), BC Cancer Agency, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of British Columbia, University of Cologne, Genentech, University of Milan, University of Utah, Georgetown University Medical Center, Royal Bournemouth Hospital, Auckland City Hospital, Institut Gustave Roussy, University Hospital Heidelberg, Yale University, Tango Therapeutics (United States), Institute of Oncology Prof. Dr. Ion Chiricuta, Instituto Português de Oncologia Francisco Gentil, National Center for Tumor Diseases, Roche (United Kingdom), Universitätsmedizin Göttingen, Hospital Universitario de La Princesa, Centre Antoine Lacassagne, University Hospital Cologne, European Institute of Oncology, University of Göttingen, Bournemouth University
OpenAlex ID: A5078425798